UnitedHealth Group Incorporated (NYSE:UNH) is Harbor Investment Advisory LLC’s 7th Largest Position

Harbor Investment Advisory LLC lessened its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 0.7% in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 34,565 shares of the healthcare conglomerate’s stock after selling 256 shares during the quarter. UnitedHealth Group comprises about 1.5% of Harbor Investment Advisory LLC’s holdings, making the stock its 7th largest holding. Harbor Investment Advisory LLC’s holdings in UnitedHealth Group were worth $17,485,000 as of its most recent filing with the SEC.

Several other large investors also recently added to or reduced their stakes in the stock. EverSource Wealth Advisors LLC boosted its stake in shares of UnitedHealth Group by 7.9% in the 2nd quarter. EverSource Wealth Advisors LLC now owns 2,622 shares of the healthcare conglomerate’s stock valued at $1,335,000 after buying an additional 193 shares during the period. Commonwealth Financial Services LLC increased its position in UnitedHealth Group by 9.0% in the 2nd quarter. Commonwealth Financial Services LLC now owns 726 shares of the healthcare conglomerate’s stock valued at $355,000 after acquiring an additional 60 shares during the period. Public Sector Pension Investment Board lifted its stake in shares of UnitedHealth Group by 26.3% in the 2nd quarter. Public Sector Pension Investment Board now owns 436,747 shares of the healthcare conglomerate’s stock worth $222,418,000 after acquiring an additional 91,022 shares during the period. Magnetar Financial LLC boosted its holdings in UnitedHealth Group by 100.7% in the 2nd quarter. Magnetar Financial LLC now owns 159,239 shares of the healthcare conglomerate’s stock valued at $81,094,000 after purchasing an additional 79,898 shares in the last quarter. Finally, Evergreen Capital Management LLC increased its holdings in shares of UnitedHealth Group by 7.7% in the 2nd quarter. Evergreen Capital Management LLC now owns 17,644 shares of the healthcare conglomerate’s stock valued at $8,985,000 after purchasing an additional 1,259 shares in the last quarter. 87.86% of the stock is currently owned by hedge funds and other institutional investors.

UnitedHealth Group Trading Down 0.1 %

Shares of UNH opened at $510.03 on Tuesday. UnitedHealth Group Incorporated has a 52-week low of $436.38 and a 52-week high of $630.73. The stock has a fifty day moving average price of $549.37 and a two-hundred day moving average price of $563.70. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.83. The company has a market cap of $469.37 billion, a price-to-earnings ratio of 32.91, a PEG ratio of 1.39 and a beta of 0.62.

UnitedHealth Group (NYSE:UNH) last released its earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share for the quarter, beating the consensus estimate of $6.74 by $0.07. The firm had revenue of $100.81 billion for the quarter, compared to analyst estimates of $101.60 billion. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The company’s quarterly revenue was up 6.8% on a year-over-year basis. During the same quarter in the prior year, the firm posted $5.83 earnings per share. Analysts predict that UnitedHealth Group Incorporated will post 29.77 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Tuesday, December 17th. Shareholders of record on Monday, December 9th were paid a $2.10 dividend. The ex-dividend date of this dividend was Monday, December 9th. This represents a $8.40 dividend on an annualized basis and a yield of 1.65%. UnitedHealth Group’s dividend payout ratio is 54.19%.

Analyst Ratings Changes

Several research firms have weighed in on UNH. Hsbc Global Res upgraded shares of UnitedHealth Group from a “hold” rating to a “strong-buy” rating in a report on Friday, January 10th. Morgan Stanley decreased their price objective on UnitedHealth Group from $615.00 to $610.00 and set an “overweight” rating on the stock in a research note on Wednesday, October 16th. Stephens upped their target price on shares of UnitedHealth Group from $605.00 to $675.00 and gave the company an “overweight” rating in a report on Thursday, December 5th. KeyCorp reissued an “overweight” rating and set a $650.00 price objective on shares of UnitedHealth Group in a research note on Friday. Finally, UBS Group reduced their price target on UnitedHealth Group from $680.00 to $650.00 and set a “buy” rating on the stock in a research note on Wednesday, October 16th. Two investment analysts have rated the stock with a hold rating, nineteen have issued a buy rating and two have given a strong buy rating to the company’s stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Buy” and a consensus price target of $627.74.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.